
Please try another search
Gilead Sciences, Inc. (NASDAQ: NASDAQ:GILD) climbed on Wednesday, even as the S&P 500 ended the day with losses.
On CNBC's "Options Action," Tony Zhang said that Gilead Sciences traded nearly 2.5 times its average daily volume on Thursday.
Check out other stocks making big moves in the premarket.
There was a buyer of more than 11,000 of the September 62.5 calls at $2.43 per contract on average, Zhang mentioned. The trader “clearly sees very limited upside for Gilead,” he added. The seller expects shares of Gilead Sciences to remain below $62.50 by September expiration.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Read at Benzinga
By Ambar Warrick Investing.com-- Chinese property developer Country Garden Holdings Company Ltd (HK:2007) said on Thursday that its profit for the first half of 2022 is...
By Katanga Johnson and Michelle Price WASHINGTON (Reuters) - While the U.S. securities regulator is likely to examine Elon Musk's tweet in which he joked about buying New...
Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.